OFM
SYRS
Omega Fund Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-251,270
| Closed | -$57.8K | – | 14 |
|
|
2024
Q4 | $57.8K | Hold |
251,270
| – | – | 0.04% | 12 |
|
|
2024
Q3 | $540K | Hold |
251,270
| – | – | 0.34% | 11 |
|
|
2024
Q2 | $1.3M | Hold |
251,270
| – | – | 0.96% | 10 |
|
|
2024
Q1 | $1.34M | Hold |
251,270
| – | – | 0.87% | 10 |
|
|
2023
Q4 | $1.96M | Hold |
251,270
| – | – | 1.59% | 12 |
|
|
2023
Q3 | $993K | Hold |
251,270
| – | – | 0.91% | 11 |
|
|
2023
Q2 | $792K | Hold |
251,270
| – | – | 0.44% | 11 |
|
|
2023
Q1 | $671K | Hold |
251,270
| – | – | 0.44% | 12 |
|
|
2022
Q4 | $902K | Hold |
251,270
| – | – | 0.3% | 14 |
|
|
2022
Q3 | $1.62M | Sell |
251,270
-2,261,435
| -90% | -$14.6M | 0.59% | 16 |
|
|
2022
Q2 | $2.42M | Hold |
2,512,705
| – | – | 0.77% | 17 |
|
|
2022
Q1 | $2.99M | Hold |
2,512,705
| – | – | 0.61% | 19 |
|
|
2021
Q4 | $8.19M | Hold |
2,512,705
| – | – | 1.16% | 16 |
|
|
2021
Q3 | $11.2M | Buy |
2,512,705
+237,874
| +10% | +$1.06M | 1.26% | 16 |
|
|
2021
Q2 | $12.4M | Buy |
2,274,831
+712,331
| +46% | +$3.88M | 1.4% | 13 |
|
|
2021
Q1 | $11.7M | Hold |
1,562,500
| – | – | 1.11% | 15 |
|
|
2020
Q4 | $17M | Buy |
+1,562,500
| New | +$17M | 2.54% | 10 |
|